Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models
Abstract Background Radiation injury can be indistinguishable from recurrent tumor on standard imaging. Current protocols for this differential diagnosis require one or more follow-up imaging studies, long dynamic acquisitions, or complex image post-processing; despite much research, the inability t...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-07-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-018-0399-z |
id |
doaj-3f947d958e0241a2a07b1ad001ca3df4 |
---|---|
record_format |
Article |
spelling |
doaj-3f947d958e0241a2a07b1ad001ca3df42020-11-25T02:01:47ZengSpringerOpenEJNMMI Research2191-219X2018-07-018111010.1186/s13550-018-0399-zDiscriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse modelsPatrick L. Donabedian0Susanne Kossatz1John A. Engelbach2Stephen A. Jannetti3Brandon Carney4Robert J. Young5Wolfgang A. Weber6Joel R. Garbow7Thomas Reiner8Department of Radiology, Memorial Sloan-Kettering Cancer CenterDepartment of Radiology, Memorial Sloan-Kettering Cancer CenterDepartment of Radiology, Washington UniversityDepartment of Radiology, Memorial Sloan-Kettering Cancer CenterDepartment of Radiology, Memorial Sloan-Kettering Cancer CenterDepartment of Radiology, Memorial Sloan-Kettering Cancer CenterDepartment of Radiology, Memorial Sloan-Kettering Cancer CenterDepartment of Radiology, Washington UniversityDepartment of Radiology, Memorial Sloan-Kettering Cancer CenterAbstract Background Radiation injury can be indistinguishable from recurrent tumor on standard imaging. Current protocols for this differential diagnosis require one or more follow-up imaging studies, long dynamic acquisitions, or complex image post-processing; despite much research, the inability to confidently distinguish between these two entities continues to pose a significant dilemma for the treating clinician. Using mouse models of both glioblastoma and radiation necrosis, we tested the potential of poly(ADP-ribose) polymerase (PARP)-targeted PET imaging with [18F]PARPi to better discriminate radiation injury from tumor. Results In mice with experimental radiation necrosis, lesion uptake on [18F]PARPi-PET was similar to contralateral uptake (1.02 ± 0.26 lesion/contralateral %IA/ccmax ratio), while [18F]FET-PET clearly delineated the contrast-enhancing region on MR (2.12 ± 0.16 lesion/contralateral %IA/ccmax ratio). In mice with focal intracranial U251 xenografts, tumor visualization on PARPi-PET was superior to FET-PET, and lesion-to-contralateral activity ratios (max/max, p = 0.034) were higher on PARPi-PET than on FET-PET. Conclusions A murine model of radiation necrosis does not demonstrate [18F]PARPi avidity, and [18F]PARPi-PET is better than [18F]FET-PET in distinguishing radiation injury from brain tumor. [18F]PARPi-PET can be used for discrimination between recurrent tumor and radiation injury within a single, static imaging session, which may be of value to resolve a common dilemma in neuro-oncology.http://link.springer.com/article/10.1186/s13550-018-0399-zPET/CTPARP1Radiation necrosisRadiation injuryAmino acid PETBiomarkers |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Patrick L. Donabedian Susanne Kossatz John A. Engelbach Stephen A. Jannetti Brandon Carney Robert J. Young Wolfgang A. Weber Joel R. Garbow Thomas Reiner |
spellingShingle |
Patrick L. Donabedian Susanne Kossatz John A. Engelbach Stephen A. Jannetti Brandon Carney Robert J. Young Wolfgang A. Weber Joel R. Garbow Thomas Reiner Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models EJNMMI Research PET/CT PARP1 Radiation necrosis Radiation injury Amino acid PET Biomarkers |
author_facet |
Patrick L. Donabedian Susanne Kossatz John A. Engelbach Stephen A. Jannetti Brandon Carney Robert J. Young Wolfgang A. Weber Joel R. Garbow Thomas Reiner |
author_sort |
Patrick L. Donabedian |
title |
Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models |
title_short |
Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models |
title_full |
Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models |
title_fullStr |
Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models |
title_full_unstemmed |
Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models |
title_sort |
discriminating radiation injury from recurrent tumor with [18f]parpi and amino acid pet in mouse models |
publisher |
SpringerOpen |
series |
EJNMMI Research |
issn |
2191-219X |
publishDate |
2018-07-01 |
description |
Abstract Background Radiation injury can be indistinguishable from recurrent tumor on standard imaging. Current protocols for this differential diagnosis require one or more follow-up imaging studies, long dynamic acquisitions, or complex image post-processing; despite much research, the inability to confidently distinguish between these two entities continues to pose a significant dilemma for the treating clinician. Using mouse models of both glioblastoma and radiation necrosis, we tested the potential of poly(ADP-ribose) polymerase (PARP)-targeted PET imaging with [18F]PARPi to better discriminate radiation injury from tumor. Results In mice with experimental radiation necrosis, lesion uptake on [18F]PARPi-PET was similar to contralateral uptake (1.02 ± 0.26 lesion/contralateral %IA/ccmax ratio), while [18F]FET-PET clearly delineated the contrast-enhancing region on MR (2.12 ± 0.16 lesion/contralateral %IA/ccmax ratio). In mice with focal intracranial U251 xenografts, tumor visualization on PARPi-PET was superior to FET-PET, and lesion-to-contralateral activity ratios (max/max, p = 0.034) were higher on PARPi-PET than on FET-PET. Conclusions A murine model of radiation necrosis does not demonstrate [18F]PARPi avidity, and [18F]PARPi-PET is better than [18F]FET-PET in distinguishing radiation injury from brain tumor. [18F]PARPi-PET can be used for discrimination between recurrent tumor and radiation injury within a single, static imaging session, which may be of value to resolve a common dilemma in neuro-oncology. |
topic |
PET/CT PARP1 Radiation necrosis Radiation injury Amino acid PET Biomarkers |
url |
http://link.springer.com/article/10.1186/s13550-018-0399-z |
work_keys_str_mv |
AT patrickldonabedian discriminatingradiationinjuryfromrecurrenttumorwith18fparpiandaminoacidpetinmousemodels AT susannekossatz discriminatingradiationinjuryfromrecurrenttumorwith18fparpiandaminoacidpetinmousemodels AT johnaengelbach discriminatingradiationinjuryfromrecurrenttumorwith18fparpiandaminoacidpetinmousemodels AT stephenajannetti discriminatingradiationinjuryfromrecurrenttumorwith18fparpiandaminoacidpetinmousemodels AT brandoncarney discriminatingradiationinjuryfromrecurrenttumorwith18fparpiandaminoacidpetinmousemodels AT robertjyoung discriminatingradiationinjuryfromrecurrenttumorwith18fparpiandaminoacidpetinmousemodels AT wolfgangaweber discriminatingradiationinjuryfromrecurrenttumorwith18fparpiandaminoacidpetinmousemodels AT joelrgarbow discriminatingradiationinjuryfromrecurrenttumorwith18fparpiandaminoacidpetinmousemodels AT thomasreiner discriminatingradiationinjuryfromrecurrenttumorwith18fparpiandaminoacidpetinmousemodels |
_version_ |
1724955896461656064 |